SAB Biotherapeutics News

SAB Biotherapeutics | 424B5: Prospectus

Jan 27 05:05

SAB Biotherapeutics | EFFECT: Others

Nov 29, 2023 13:15

SAB Biotherapeutics | EFFECT: Others

Aug 31, 2023 12:15

SAB Biotherapeutics | EFFECT: Others

May 18, 2023 12:15

SAB Biotherapeutics | EFFECT: Others

May 10, 2023 12:15

SAB Biotherapeutics | 424B3: Prospectus

Mar 8, 2023 06:03

SAB Biotherapeutics | EFFECT: Others

Feb 13, 2023 13:15

SAB Biotherapeutics | EFFECT: Others

Feb 9, 2023 13:15

SAB Biotherapeutics | 424B3: Prospectus

Nov 18, 2022 22:15

SAB Biotherapeutics | 424B3: Prospectus

Aug 18, 2022 05:29

SAB Biotherapeutics | 424B3: Prospectus

Jun 7, 2022 07:02

SAB Biotherapeutics | 424B3: Prospectus

May 14, 2022 06:43

SAB Biotherapeutics | 424B3: Prospectus

Apr 30, 2022 04:16

SAB Biotherapeutics | EFFECT: Others

Apr 27, 2022 12:15

SAB Biotherapeutics | 424B3: Prospectus

Dec 30, 2021 05:01

SAB Biotherapeutics | EFFECT: Others

Dec 16, 2021 13:15

SAB Biotherapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 14, 2021 00:59

SAB Biotherapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 28, 2021 21:11

SAB Biotherapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 27, 2021 18:10

SAB Biotherapeutics | 424B3: Prospectus

Sep 25, 2021 05:01